natgillin/translations-raw huggingface dataset:
The active substance is palonosetron.
Toimeaine on palonosetroon.
The active substance is pancreas powder of porcine origin.
Toimeaine on sigadelt pärinev pankreasepulber.
The active substance is pantoprazole.
Toimeaine on pantoprasool.
The active substance is para-aminosalicylic acid.
Toimeaine on para-aminosalitsüülhape.
The active substance is parathyroid hormone.
Toimeaine on parathormoon.
The active substance is parecoxib (as parecoxib sodium).
Toimeaine on parekoksiib (parekoksiibnaatriumina).
The active substance is pasireotide.
Toimeaine on pasireotiid.
The active substance is pegaptanib.
Toimeaine on pegaptaniibnaatrium.
The active substance is pegfilgrastim.
Toimeaine on pegfilgrastiim.
The active substance is peginterferon alfa-2a.
Toimeaine on alfa-2a-peginterferoon.
The active substance is peginterferon alfa-2b.
Toimeaine on alfa-2b-peginterferoon.
The active substance is pegloticase.
Toimeaine on peglotikaas.
The active substance is pegvisomant.
Toimeaine on pegvisomant.
The active substance is pembrolizumab.
Toimeaine on pembrolizumab.
The active substance is perflutren-containing microspheres of heat treated human albumin 5- 8 x 108/ml, suspended in human albumin solution 1%.
Toimeaine on perflutreeni sisaldavad inimese kuumutatud albumiini mikrosfäärid 5-8 x 108/ml, mis on inimese albumiini 1% suspensioonis.
The active substance is perflutren.
Toimeaine on perflutreen.
The active substance is pertuzumab.
Toimeaine on pertuzumab.
The active substance is pioglitazone.
Sepioglini toimeaine on pioglitasoon.
The active substance is pioglitazone.
Toimeaine on pioglitasoon.
The active substance is plerixafor.
Toimeaine on pleriksafoor.
The active substance is pomalidomide
Toimeaine on pomalidomiid.
The active substance is ponatinib.
Toimeaine on ponatiniib.
The active substance is porfimer sodium.
Toimeaine on porfimeernaatrium.
The active substance is posaconazole.
Toimeaine on posakonasool.
The active substance is prasugrel.
Toimeaine on prasugreel.
The active substance is present as a white powder in a blister strip inside the inhaler.
Toimeaine on valge pulbrina inhalaatori sisemuses paiknevas blisterribas.
The active substance is propranolol.
Toimeaine on 3,75 mg/ml propranolool.
The active substance is raloxifene hydrochloride.
Toimeaine on raloksifeenvesinikkloriid.
The active substance is ramucirumab.
Toimeaine on ramutsirumab.
The active substance is ranibizumab (10 mg/ml).
Toimeaine on ranibizumab (10 mg/ml).
The active substance is rasagiline.
Toimeaine on rasagiliin.
The active substance is rasburicase 1.5 mg/ml.
Toimeaine on rasburikaas 1,5 mg/ml.
The active substance is recombinant coagulation factor VIIa (activated eptacog alfa).
Toimeaine on rekombinantne hüübimisfaktor VIIa (aktiveeritud alfaeptakogi, eptacogum alfa activatum).
The active substance is recombinant human coagulation factor VIII (simoctocog alfa).
Toimeaine on rekombinantne inimese VIII hüübimisfaktor (alfasimoktokog).
The active substance is recombinant interferon alfa-2b, 10 million IU in a single dose vial
Toimeaine on rekombinantne interferoon alfa-2b, 10 miljonit RÜ üheannuselises viaalis.
The active substance is recombinant interferon alfa-2b, 18 million IU in a multiple dose vial
Toimeaine on rekombinantne interferoon alfa-2b, 18 miljonit RÜ mitmeannuselises viaalis.
The active substance is recombinant interferon alfa-2b, 18 million IU/pen
Toimeaine on rekombinantne interferoon alfa-2b, 18 miljonit RÜ/süstel.
The active substance is recombinant interferon alfa-2b, 25 million IU in a multiple dose vial
Toimeaine on rekombinantne interferoon alfa-2b, 25 miljonit RÜ mitmeannuselises viaalis.
The active substance is recombinant interferon alfa-2b, 3 million IU in a single dose vial
Toimeaine on rekombinantne interferoon alfa-2b, 3 miljonit RÜ üheannuselises viaalis.
The active substance is recombinant interferon alfa-2b, 30 million IU/pen
Toimeaine on rekombinantne interferoon alfa-2b, 30 miljonit RÜ/süstel.
The active substance is recombinant interferon alfa-2b, 5 million IU in a single dose vial
Toimeaine on rekombinantne interferoon alfa-2b, 5 miljonit RÜ üheannuselises viaalis.
The active substance is recombinant interferon alfa-2b, 60 million IU/pen
Toimeaine on rekombinantne interferoon alfa-2b, 60 miljonit RÜ/süstel.
The active substance is recombinant interferon alfa-2b.
Toimeaine on rekombinantne alfa-2b-interferoon.
The active substance is regorafenib.
Toimeaine on regorafeniib.
The active substance is reslizumab.
Toimeaine on reslizumab.
The active substance is retapamulin.
Toimeaine on retapamuliin.
The active substance is reteplase 10U/10 ml after reconstitution.
Peale lahustamist on toimeaine reteplaasi kontsentratsioon 10ühikut/10ml.
The active substance is ribavirin 200 mg.
Toimeaine on ribaviriin 200 mg.
The active substance is ribavirin.
Toimeaine on ribaviriin.
The active substance is rilonacept.
Toimeaine on rilonatsept.
The active substance is rilpivirine in the form of rilpivirine hydrochloride.
Toimeaine on rilpiviriin rilpiviriinvesinikkloriidina.
The active substance is rimonabant.
Toimeaine on rimonabant.
The active substance is riociguat.
Toimeaine on riotsiguaat.
The active substance is rivaroxaban.
Toimeaine on rivaroksabaan.
The active substance is rivastigmine hydrogen tartrate.
Toimeaine on rivastigmiinvesiniktartraat.
The active substance is rivastigmine.
Toimeaine on rivastigmiin.
The active substance is roflumilast.
Toimeaine on roflumilast.
The active substance is romiplostim.
Toimeaine on romiplostiim.
The active substance is rufinamide.
Toimeaine on rufinamiid.
The active substance is safinamide.
Toimeaine on safinamiid.
The active substance is samarium (153Sm) lexidronam pentasodium.
Toimeaine on samaarium (153Sm) pentanaatriumleksidronaam.
The active substance is sapropterin dihydrochloride.
Toimeaine on sapropteriindivesinikkloriid.
The active substance is saquinavir.
Toimeaine on sakvinaviir.
The active substance is saxagliptin.
Toimeaine on saksagliptiin.
The active substance is secukinumab.
Toimeaine on: sekukinumab.
The active substance is selexipag.
Toimeaine on seleksipaag.
The active substance is sevelamer carbonate.
Toimeaine on sevelameerkarbonaat.
The active substance is sevelamer hydrochloride.
Toimeaine on sevelameervesinikkloriid.
The active substance is sildenafil (as sildenafil citrate).
Toimeaine on sildenafiil (sildenafiiltsitraadina).
The active substance is siltuximab.
Toimeaine on siltuksimab.
The active substance is simeprevir.
Toimeaine on simepreviir.
The active substance is sitagliptin.
Toimeaine on sitagliptiin.
The active substance is sitaxentan sodium.
Toimeaine on sitaksentaannaatrium.
The active substance is sofosbuvir.
Toimeaine on sofosbuviir.
The active substance is sonidegib (as phosphate).
Toimeaine on sonidegiib (fosfaadina).
The active substance is stavudine (15 mg).
Toimeaine on stavudiin (15 mg)
The active substance is stavudine (20 mg).
Toimeaine on stavudiin (20 mg)
The active substance is stavudine (200 mg).
Toimeaine on stavudiin (200 mg)
The active substance is stavudine (30 mg).
Toimeaine on stavudiin (30 mg)
The active substance is stavudine (40 mg).
Toimeaine on stavudiin (40 mg)
The active substance is stiripentol.
Toimeaine on stiripentool.
The active substance is strontium ranelate.
Toimeaine on strontsiumranelaat.
The active substance is sufentanil.
Toimeaine on sufentaniil.
The active substance is sugammadex.
Toimeaine on sugammadeks.
The active substance is sulesomab
Toimeaine on: sulesomabi
The active substance is sulphur hexafluoride in the form of microbubbles.
Toimeaine on väävelheksafluoriid mikromullide kujul.
The active substance is susoctocog alfa (antihaemophilic Factor VIII, porcine sequence produced by recombinant DNA technology).
Toimeaine on alfasusoktokog (hemofiiliavastane faktor VIII (sea genoomi järjestus), mis on toodetud rekombinantse DNA tehnoloogiaga).
The active substance is tacrolimus.
Toimeaine on takroliimus.
The active substance is tafamidis.
Toimeaine on tafamidis.
The active substance is talimogene laherparepvec.
Toimeaine on talimogeenlaherparepvek.
The active substance is tasimelteon.
Toimeaine on tasimelteoon.
The active substance is tasonermin.
Toimeaine on tasonermiin.
The active substance is tedizolid phosphate.
Toimeaine on tedisoliidfosfaat.
The active substance is teduglutide.
Toimeaine on teduglutiid.
The active substance is telaprevir.
Toimeaine on telapreviir.
The active substance is telbivudine.
Toimeaine on telbivudiin.
The active substance is telithromycin.
Toimeaine on telitromütsiin 400 mg.
The active substance is telmisartan.
Toimeaine on telmisartaan.
The active substance is telmisartan.
Toimeaine on telmisartan.
The active substance is temoporfin.
Toimeaine on temoporfiin.
The active substance is tenecteplase.
Toimeaine on tenekteplaas.
The active substance is tenofovir.
Toimeaine on tenofoviir.
The active substance is teriflunomide.
Toimeaine on teriflunomiid.
The active substance is teriparatide.
Toimeaine on teriparatiid.
The active substance is thalidomide.
Toimeaine on talidomiid.
The active substance is thiotepa.
Toimeaine on tiotepa.
The active substance is thyrotropin alfa.
Toimeaine on alfa-türeotropiin.
The active substance is ticagrelor.
Toimeaine on tikagreloor.
The active substance is tigecycline.
Toimeaine on tigetsükliin.
The active substance is tilmanocept.
Toimeaine on tilmanotsept.
The active substance is tipranavir.
Toimeaine on tipranaviir.
The active substance is tobramycin.
Toimeaine on tobramütsiin.
The active substance is tocilizumab.
Toimeaine on totsilizumab.
The active substance is tocofersolan.
Toimeaine on tokofersolaan.
The active substance is tolcapone (100 mg in each film- coated tablet)
Toimeaine on tolkapoon (100 mg igas õhukese polümeerikattega tabletis).
The active substance is tolcapone (200 mg in each film- coated tablet)
Toimeaine on tolkapoon (200 mg igas õhukese polümeerikattega tabletis).
The active substance is tolvaptan.
Toimeaine on tolvaptaan.
The active substance is topotecan hydrochloride.
Toimeaine on topotekaanvesinikkloriid.
The active substance is topotecan.
Toimeaine on topotekaan.
The active substance is toremifene; each tablet contains 60 mg (as citrate).
Toimeaine on toremifeen; iga tablett sisaldab 60 mg (tsitraadina).
The active substance is trabectedin.
Toimeaine on trabektediin.
The active substance is trametinib.
Toimeaine on trametiniib.
The active substance is trastuzumab emtansine.
Toimeaine on trastuzumabemtansiin.
The active substance is trastuzumab.
Toimeaine on trastuzumab.
The active substance is travoprost 40 micrograms/ml.
Toimeaine on travoprost 40 mikrogrammi/ml.
The active substance is travoprost.
Toimeaine on travoprost.
The active substance is turoctocog alfa (human coagulation factor VIII (rDNA)).
Toimeaine on alfaturoktokog (inimese VIII hüübimisfaktor (rDNA)).
The active substance is ulipristal acetate.
Toimeaine on ulipristaalatsetaat.
The active substance is umeclidinium bromide.
Toimeaine on umeklidiiniumbromiid.
The active substance is ustekinumab.
Toimeaine on ustekinumab.
The active substance is vandetanib.
Toimeaine on vandetaniib.
The active substance is vardenafil.
Toimeaine on vardenafiil.
The active substance is varenicline
Toimeaine on varenikliin
The active substance is velaglucerase alfa.
Toimeaine on alfavelaglütseraas.
The active substance is vemurafenib.
Toimeaine on vemurafeniib.
The active substance is vernakalant hydrochloride.
Toimeaine on vernakalantvesinikkloriid.
The active substance is verteporfin.
Toimeaine on verteporfiin.
The active substance is vildagliptin.
Toimeaine on vildagliptiin.
The active substance is vinflunine.
Toimeaine on vinfluniin.
The active substance is vismodegib.
Toimeaine on vismodegiib.
The active substance is vorapaxar sulfate.
Toimeaine on vorapaksaarsulfaat.
The active substance is voriconazole.
Toimeaine on vorikonasool.
The active substance is vortioxetine.
Toimeaine on vortioksetiin.
The active substance is Yttrium (90Y) chloride.
Toimeaine on ütrium (90Y) kloriid.
The active substance is Yttrium (90Y) chloride.
Toimeaine on ütriumkloriid (90Y).
The active substance is ziconotide.
Toimeaine on zikonotiid.
The active substance is zoledronic acid.
Toimeaine on zoledroonhape.
The active substance is zonisamide.
Toimeaine on zonisamiid.
The active substance is:
Toimeaine on
The active substance is: aflibercept.
Toimeaine on aflibertsept.
The active substance is: epoetin alfa (for quantity see the table below).
Toimeaine on alfaepoetiin (kogused vt allolevast tabelist).
The active substance is: radium Ra 223 dichloride (radium-223 dichloride).
Toimeaine on raadium Ra 223 dikloriid (raadium-223 dikloriid).
The active substance metformin works mainly by blocking glucose production in the liver and reducing its absorption in the gut.
Metformiini toime seisneb põhiliselt glükoosi tekke pärssimises maksas ja selle sooles imendumise vähendamises.
The active substance of Aranesp is darbepoetin alfa produced by gene-technology in Chinese Hamster Ovary Cells (CHO-K1).
Aranesp’i toimeaine alfadarbepoetiin, mida toodetakse geenitehnoloogia abil hiina hamstri munarakkudes (CHO-K1).
The active substance of Aranesp is darbepoetin alfa produced by gene-technology in Chinese Hamster Ovary Cells (CHO-K1).
Aranesp’i toimeaine on alfadarbepoetiin, mida toodetakse geenitehnoloogia abil hiina hamstri munarakkudes (CHO-K1).
The active substance of Atriance is nelarabine.
Atriance toimeaine on nelarabiin.
The active substance of ChondroCelect consists of a treatment dose of viable autologous human cartilage cells in vials containing 4 million cells in 0.4 ml, corresponding to a concentration of 10,000 cells/microlitre.
ChondroCelecti toimeaineks on inimese elusad autoloogsed kõhrerakud raviannusena viaalides, mis sisaldavad 4 miljonit rakku 0,4 ml rakususpensioonina, mis vastab kontsentratsioonile 10 000 rakku mikroliitri kohta.
The active substance of Exelon is rivastigmine.
Exelon’i toimeaine on rivastigmiin.
The active substance of Exelon is rivastigmine.
Exelon’is sisalduv toimeaine on rivastigmiin.
The active substance of FORCALTONIN is recombinant salmon calcitonin.
FORCALTONIN’i toimeaine on rekombinantne lõhe kaltsitoniin.
The active substance of Forcaltonin, salmon calcitonin, is a copy of the hormone produced by a method known as ‘recombinant DNA technology’: it is made by a cell that has received a gene (DNA), which makes it able to produce salmon calcitonin.
Forcaltonini toimeaine lõhe kaltsitoniin on hormooni analoog, mida toodetakse rekombinant-DNA-tehnikana tuntud meetodil: seda toodab rakk, millesse on viidud lõhe kaltsitoniini tootmist võimaldav geen (DNA).
The active substance of Galvus, vildagliptin, belongs to a group of medicines called “oral antidiabetics”.
Galvus’e toimeaine vildagliptiin kuulub ravimite rühma, mida nimetatakse „suukaudseteks diabeediravimiteks”.
The active substance of Gilenya is fingolimod.
Gilenya toimeaine on fingolimood.
The active substance of Jakavi is ruxolitinib.
Jakavi toimeaine on ruksolitiniib.
The active substance of KIOVIG is human normal immunoglobulin.
KIOVIGi toimeaine on inimese normaalne immunoglobuliin.
The active substance of Levviax is telithromycin, an antibacterial medicinal product which is a novel semi-synthetic antibacterial agent belonging to a new family of antibiotics, the ketolides, closely related to the well-known macrolide antibiotics.
Levviax'i toimeaine telitromütsiin on antibakteriaalne ravimpreparaat, uudne poolsünteetiline antibakteriaalne aine, mis kuulub makroliididele lähedasse uude antibiootikumide klassi – ketoliidid.
The active substance of MACI consists of viable autologous human cartilage cells on a 14.5 cm² Type I/III collagen membrane, at a density of between 0.5 and 1 million cells per cm2.
MACI toimeaine on inimese elujõulised autoloogsed kõhrerakud 14,5 cm² I/III tüüpi kollageenmembraanil tihedusega 0,5 kuni 1 miljon rakku cm2 kohta.
The active substance of Masivet can cause severe eye-irritation and serious damage to the eyes.
Masiveti toimeaine võib põhjustada tugevat silmaärritust ja raskeid silmakahjustusi.
The active substance of Nimvastid is rivastigmine.
Nimvastid’is sisalduv toimeaine on rivastigmiin.
The active substance of Pixuvri is pixantrone , a cytotoxic aza-anthracenedione.
Pixuvri toimeaine on piksantroon, tsütotoksiline asa-antratsenedioon.
The active substance of Prometax is rivastigmine.
Prometax’i toimeaine on rivastigmiin.
The active substance of Prometax is rivastigmine.
Prometax’is sisalduv toimeaine on rivastigmiin.
The active substance of Protopic, tacrolimus monohydrate, is an immunomodulating agent.
Protopic’u toimeaine takroliimusmonohüdraat on immuunmoduleeriv aine.
The active substance of Protopy, tacrolimus monohydrate, is an immunomodulating agent.
Protopy’u toimeaine takroliimusmonohüdraat on immuunmoduleeriv aine.
The active substance of Rivastigmine 1 A Pharma is rivastigmine.
Rivastigmine 1 A Pharma’s sisalduv toimeaine on rivastigmiin.
The active substance of Rivastigmine Actavis is rivastigmine.
Rivastigmine Actavis’es sisalduv toimeaine on rivastigmiin.
The active substance of Rivastigmine HEXAL is rivastigmine.
Rivastigmine HEXAL’is sisalduv toimeaine on rivastigmiin.
The active substance of Rivastigmine Sandoz is rivastigmine.
Rivastigmine Sandoz s sisalduv toimeaine on rivastigmiin.
The active substance of Rivastigmine Sandoz is rivastigmine.
Rivastigmine Sandoz ’is sisalduv toimeaine on rivastigmiin.
The active substance of Rivastigmine Teva is rivastigmine
Rivastigmine Teva’s sisalduv toimeaine on rivastigmiin.
The active substance of Siklos, i.e. hydroxycarbamide, is a substance which inhibits growth and proliferation of some cells, such as blood cells.
Sikloses sisalduv toimeaine hüdroksükarbamiid on aine, mis takistab teatud rakkude, nt vererakkude, kasvu ja paljunemist.
The active substance of Tarceva is erlotinib.
Toimeaine on erlotiniib.
The active substance of Vaniqa is eflornithine.
Vaniqa toimeaine on eflornitiin.
The active substance of Vargatef is nintedanib.
Vargatefi toimeaine on nintedaniib.
The active substance of Ventavis is iloprost.
Ventavis’e toimeaine on iloprost.
The active substance of Virbagen Omega, omega interferon, is produced by a method known as ‘recombinant technology’.
Virbagen Omega toimeainet interferoon-oomegat toodetakse rekombinanttehnika abil.
The active substance of VPRIV is velaglucerase alfa, which is produced by gene activation technology in a human cell line.
VPRIV’is sisalduv toimeaine on alfavelaglütseraas, mida valmistatakse geeni aktiveerimise tehnoloogia abil inimese rakuliinis.
The active substance of Xiliarx, vildagliptin, belongs to a group of medicines called “oral antidiabetics”.
Xiliarx’i toimeaine vildagliptiin kuulub ravimite rühma, mida nimetatakse „suukaudseteks diabeediravimiteks”.
The active substance of Xolair is omalizumab.
Xolair’i toimeaine on omalizumab.
The active substance of ZACTRAN, gamithromycin, is an antibiotic of the macrolide group.
ZACTRANi toimeaine gamitromütsiin on makroliidide rühma kuuluv antibiootikum.
The active substance of Zoledronic Acid Hospira 4 mg/100 ml solution for infusion is zoledronic acid.
Zoledronic Acid Hospira 4 mg/100 ml infusioonilahuse toimeaine on zoledroonhape.
The active substance of Zoledronic Acid Hospira is zoledronic acid.
Zoledronic Acid Hospira toimeaine on zoledroonhape.
The active substance oxybutynin is persistent in the environment.
Toimeaine oksübutüniin on keskkonnas püsiv.
The active substance oxybutynin is persistent in the environment.
Toimeaine oksübutüniin on keskonnas püsiv.
The active substance stimulates active immunity against Aujeszky’s disease in pigs.
Toimeaine stimuleerib aktiivse immuunsuse tekkimist Aujeszky haiguse vastu sigadel.
The active substance tenofovir disoproxil fumarate and its main transformation products are persistent in the environment.
Toimeaine tenofoviirdisoproksiilfumaraat ja selle peamised muundumissaadused on keskkonnas püsivad.
The active substance, Halofuginone, is an antiprotozoal agent of the quinazolinone derivatives group (nitrogenous polyheterocycles).
Toimeaine halofuginoon on antiprotosoikum, mis kuulub kvinasolinooni derivaatide gruppi (lämmastikku sisaldavad polüheterotsüklilised ained).
The active substance, levetiracetam, is a pyrrolidone derivative (S-enantiomer of α-ethyl-2-oxo-1- pyrrolidine acetamide), chemically unrelated to existing antiepileptic active substances.
Toimeaine levetiratsetaam on pürrolidooni derivaat (alfa-etüül-2-okso-1-pürrolidiinatsetamiidi S- enantiomeer), mis ei ole keemiliselt sarnane olemasolevate epilepsiavastaste toimeainetega.
The active substance, levetiracetam, is a pyrrolidone derivative (S-enantiomer of α-ethyl-2-oxo-1- pyrrolidine acetamide), chemically unrelated to existing antiepileptic active substances.
Toimeaine levetiratsetaam on pürrolidooni derivaat (α-etüül-2-okso-1-pürrolidiinatsetamiidi S-enantiomeer), mis ei ole keemiliselt sarnane olemasolevate epilepsiavastaste toimeainetega.
The active substance, levetiracetam, is a pyrrolidone derivative (S-enantiomer of α-ethyl-2-oxo-1-pyrrolidine acetamide), chemically unrelated to existing antiepileptic active substances.
Toimeaine levetiratsetaam on pürrolidooni derivaat (α-etüül-2-okso-1-pürrolidiinatsetamiidi S- enantiomeer), mis ei ole keemiliselt sarnane olemasolevate epilepsiavastaste toimeainetega.
The active substance, levetiracetam, is a pyrrolidone derivative (S-enantiomer of -ethyl-2-oxo-1- pyrrolidine acetamide), chemically unrelated to existing antiepileptic active substances.
Toimeaine levetiratsetaam on pürrolidooni derivaat (alfa-etüül-2-okso-1-pürrolidiinatsetamiidi S- enantiomeer), mis ei ole keemiliselt sarnane olemasolevate epilepsiavastaste toimeainetega.
The active substance, levetiracetam, is a pyrrolidone derivative (S-enantiomer of -ethyl-2-oxo-1- pyrrolidine acetamide), chemically unrelated to existing antiepileptic active substances.
Toimeaine levetiratsetaam on pürrolidooni derivaat (α-etüül-2-okso-1-pürrolidiinatsetamiidi S- enantiomeer), mis ei ole keemiliselt sarnane olemasolevate epilepsiavastaste toimeainetega.
The active substance, PAS, is a ‘bacteriostatic agent’, which means that it works by stopping the growth of M. tuberculosis bacteria.
Toimeaine para-aminosalitsüülhape on bakteriostaatiline aine, mis tähendab, et selle toime peatab bakteri M. tuberculosis kasvu.
The active substance, pregabalin, is a gamma-aminobutyric acid analogue ((S)-3-(aminomethyl)-5- methylhexanoic acid).
Toimeaine pregabaliin on gamma-aminobutüürhappe (GABA, gamma-aminobutyric acid) analoog [(S)-3-(aminometüül)-5-metüülheksanoehape].
The active substance, pregabalin, is a gamma-aminobutyric acid analogue [(S)-3- (aminomethyl)-5- methylhexanoic acid].
Toimeaine pregabaliin on gamma-aminobutüürhappe (GABA, gamma-aminobutyric acid) analoog [(S)-3-(aminometüül)-5-metüülheksanoehape].
The active substance, pregabalin, is a gamma-aminobutyric acid analogue [(S)-3- (aminomethyl)-5-methylhexanoic acid].
Toimeaine pregabaliin on gamma-aminobutüürhappe (GABA, gamma-aminobutyric acid ) analoog [(S)-3-(aminometüül)-5-metüülheksanoehape].
The active substance, pregabalin, is a gamma-aminobutyric acid analogue [(S)-3-(aminomethyl)- 5- methylhexanoic acid].
Toimeaine pregabaliin on gamma-aminobutüürhappe (GABA, gamma-aminobutyric acid) analoog [(S)-3-(aminometüül)-5-metüülheksanoehape].
The active substance, pregabalin, is a gamma-aminobutyric acid analogue [(S)3(aminomethyl)5- methylhexanoic acid].
Toimeaine pregabaliin on gamma-aminobutüürhappe (GABA, gamma-aminobutyric acid ) analoog [(S)-3-(aminometüül)-5-metüülheksanoehape].
The active substance, pregabalin, is a gamma-aminobutyric- acid analogue [(S)-3-(aminomethyl-- 5-methylhexanoic acid].
Toimeaine pregabaliin on gamma-aminobutüürhappe (GABA, gamma-aminobutyric acid) analoog [(S)-3-(aminometüül)-5-metüülheksanoehape].
The active substances are aclidinium bromide and formoterol fumarate dihydrate.
Toimeained on aklidiiniumbromiid ja formoteroolfumaraatdihüdraat.
The active substances are alogliptin and metformin hydrochloride.
Toimeained on alogliptiin ja metformiinvesinikkloriid.
The active substances are alogliptin and pioglitazone.
Toimeained on alogliptiin ja pioglitasoon.